PMT: net income $30.9M. PMT sells MSR portfolio, pivots to subordinate MBS as loan purchases fall 310.4%

Filed August 4, 2026 · Period ending June 30, 2026 · Compared to 10-Q Jul 30, 2025 · ~2 min read

Key Changes

• high

  Subsequent event: Management has evaluated all events and transactions through the date the Company issued these consolidated financial statements. During this period, • During June 2026, the Company entered into an agreement to sell a…

  Notes: Subsequent Events verify on EDGAR →
• high

  Agreed to sell $13 billion UPB of conventional MSRs in June 2026, expected to close in August. Management disclosed a strategic shift to decrease MSR exposure and increase subordinate MBS holdings, with additional MSR sales possible in future periods.

  MD&A: Strategic shift to subordinate MBS verify on EDGAR →
• high

  Correspondent loan purchases collapsed 82% year-over-year to $10 billion (from $55.4 billion) as PMT now selectively acquires only certain loan types from PLS rather than purchasing directly from correspondent sellers. Starting Q3 2026, PMT will purchase only non-Agency loans from PLS, exiting conventional conforming purchases entirely.

  MD&A: Correspondent loan sourcing change verify on EDGAR →